Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $287.7M | $462.7M | $738.4M | $1,674.5M | $1,637.1M | $1,679.6M | $1,789.3M | $2,002.7M | $2,492.3M | $2,530.7M | $2,705.0M | $2,832.7M | $3,058.8M | $3,217.9M | $3,367.3M | $3,776.4M | $5,632.3M | $4,862.8M | $4,030.4M | $4,030.3M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Hologic, Inc.'s last 12-month Revenue is $4,030.2M, based on the financial report for Sep 28, 2024 (Q3 2024).
Over the last year, Hologic, Inc.'s Revenue growth was (0.0%). The average annual Revenue growth rates for Hologic, Inc. have been (8.8%) over the past three years, 3.7% over the past five years.
Over the last year, Hologic, Inc.'s Revenue growth was (0.0%), which is lower than industry growth of 0.0%. It indicates that Hologic, Inc.'s Revenue growth is Bad.